Skip to main content

IDWeek 2023 Main banner

Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

David W. Liu, BA

Director of Compliance & Project Management
Aerium Therapeutics

Poster(s):

(360) A First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies

Thursday, October 12, 2023
12:15 PM – 1:30 PM US ET